Literature DB >> 16339512

Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor.

Hatice Aldemir1, Virginie Prod'homme, Marie-Jeanne Dumaurier, Christelle Retiere, Gwenola Poupon, Julie Cazareth, Franck Bihl, Veronique M Braud.   

Abstract

Human NK cells and subsets of T cells or NKT cells express the orphan C-type lectin receptor CD161 (NKR-P1A) of unknown function. In contrast to rodents that possess several NKR-P1 genes coding for either activating or inhibitory receptors, the nature of signals delivered by the single human NKR-P1A receptor is still to be clarified. In this article, we show that the lectin-like transcript 1 (LLT1) molecule is a ligand for the CD161 receptor. Engagement of CD161 on NK cells with LLT1 expressed on target cells inhibited NK cell-mediated cytotoxicity and IFN-gamma secretion. Conversely, LLT1/CD161 interaction in the presence of a TCR signal enhanced IFN-gamma production by T cells. These findings identify a novel ligand/receptor pair that differentially regulate NK and T cell functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16339512     DOI: 10.4049/jimmunol.175.12.7791

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  113 in total

Review 1.  Intraepithelial lymphocytes in celiac disease immunopathology.

Authors:  Valérie Abadie; Valentina Discepolo; Bana Jabri
Journal:  Semin Immunopathol       Date:  2012-06-03       Impact factor: 9.623

2.  Langerhans cells from human cutaneous squamous cell carcinoma induce strong type 1 immunity.

Authors:  Hideki Fujita; Mayte Suárez-Fariñas; Hiroshi Mitsui; Juana Gonzalez; Mark J Bluth; Shali Zhang; Diane Felsen; James G Krueger; John A Carucci
Journal:  J Invest Dermatol       Date:  2012-03-08       Impact factor: 8.551

3.  Structure of the H107R variant of the extracellular domain of mouse NKR-P1A at 2.3 Å resolution.

Authors:  Petr Kolenko; Daniel Rozbeský; Ondřej Vaněk; Karel Bezouška; Jindřich Hašek; Jan Dohnálek
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-11-30

4.  The Activating C-type Lectin-like Receptor NKp65 Signals through a Hemi-immunoreceptor Tyrosine-based Activation Motif (hemITAM) and Spleen Tyrosine Kinase (Syk).

Authors:  Björn Bauer; Tanja Wotapek; Tobias Zöller; Emilia Rutkowski; Alexander Steinle
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

5.  Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells.

Authors:  Armando M Marrufo; Stephen O Mathew; Pankaj Chaudhary; Joseph D Malaer; Jamboor K Vishwanatha; Porunelloor A Mathew
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

6.  Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome.

Authors:  Véronique M Braud; Jérôme Biton; Etienne Becht; Samantha Knockaert; Audrey Mansuet-Lupo; Estelle Cosson; Diane Damotte; Marco Alifano; Pierre Validire; Fabienne Anjuère; Isabelle Cremer; Nicolas Girard; Dominique Gossot; Agathe Seguin-Givelet; Marie-Caroline Dieu-Nosjean; Claire Germain
Journal:  Oncoimmunology       Date:  2018-01-29       Impact factor: 8.110

7.  NKR-P1B expression in gut-associated innate lymphoid cells is required for the control of gastrointestinal tract infections.

Authors:  Elias Abou-Samra; Zachary Hickey; Oscar A Aguilar; Michal Scur; Ahmad Bakur Mahmoud; Sergey Pyatibrat; Megan M Tu; Jeffrey Francispillai; Arthur Mortha; James R Carlyle; Mir Munir A Rahim; Andrew P Makrigiannis
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

8.  Seasonal Variability and Shared Molecular Signatures of Inactivated Influenza Vaccination in Young and Older Adults.

Authors:  Stefan Avey; Subhasis Mohanty; Daniel G Chawla; Hailong Meng; Thilinie Bandaranayake; Ikuyo Ueda; Heidi J Zapata; Koonam Park; Tamara P Blevins; Sui Tsang; Robert B Belshe; Susan M Kaech; Albert C Shaw; Steven H Kleinstein
Journal:  J Immunol       Date:  2020-02-14       Impact factor: 5.422

Review 9.  Natural killer cell receptors and their ligands in liver diseases.

Authors:  Satoshi Yamagiwa; Hiroteru Kamimura; Takafumi Ichida
Journal:  Med Mol Morphol       Date:  2009-03-18       Impact factor: 2.309

10.  Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells.

Authors:  David B Rosen; Wei Cao; Danielle T Avery; Stuart G Tangye; Yong-Jun Liu; J P Houchins; Lewis L Lanier
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.